重组人类红细胞生成素可有效地治疗慢性肾功能衰竭患者的贫血。使患者的工作能力提高、主观感觉改善、心脏指数减低。但是,有人认为可能会使高血压和肾功能恶化。作者为此进行了研究。对象和方法:所研究的26例患者的血清肌酐值为2.3～11.7mg/dl。随访期为2.7～24个月。依血清肌酐值倒数与时间的回归线斜率来评价肾功能。26例患者中,10例接受了重组人类红细胞生成素并使贫血得到了纠正;另16例未接受重组人类红细胞生成素的患者 Recombinant human erythropoietin is effective in the treatment of anemia in patients with chronic renal failure. The patient’s ability to work to improve the subjective feeling of improvement, reduced cardiac index. However, some people think that may cause high blood pressure and renal function deterioration. The author studied this. Subjects and Methods: The 26 patients studied had a serum creatinine value of 2.3 to 11.7 mg / dl. The follow-up period was 2.7-24 months. Renal function was evaluated by the regression line slope of serum creatinine value versus time. Of the 26 patients, 10 received recombinant human erythropoietin and corrected the anemia; the other 16 patients who did not receive recombinant human erythropoietin